Medicine and Dentistry
Biological Marker
100%
Prostate Cancer
100%
Androgen Receptor
100%
Circulating Tumor Cell
100%
Patient
83%
Chemotherapy
33%
Therapeutic Procedure
33%
Castration Resistant Prostate Cancer
33%
Prognosis
33%
Assay
16%
Disease
16%
Assessment
16%
Survival
16%
Prognostic Factor
16%
Cell Count
16%
Abiraterone
16%
Enzalutamide
16%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Neoplasm
100%
Prostate Cancer
100%
Androgen Receptor
100%
Castration Resistant Prostate Cancer
33%
Prognosis
33%
Diseases
16%
Survival
16%
Enzalutamide
16%
Abiraterone
16%
Taxane
16%
Immunology and Microbiology
Circulating Tumor Cell
100%
Electric Potential
33%
Prostate
33%
Survival
16%
Mutation
16%
Cell Count
16%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Electric Potential
33%
Mutation
16%
Survival
16%
Cell Count
16%
Enzalutamide
16%